- Home
- CRGO vs EPRX Comparison
CRGO vs EPRX Comparison
Compare CRGO & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- EPRX
- Stock Information
- Founded
- CRGO 2012
- EPRX 2011
- Country
- CRGO Israel
- EPRX Canada
- Employees
- CRGO N/A
- EPRX N/A
- Industry
- CRGO Blank Checks
- EPRX
- Sector
- CRGO Finance
- EPRX
- Exchange
- CRGO Nasdaq
- EPRX NYSE
- Market Cap
- CRGO 106.1M
- EPRX 109.7M
- IPO Year
- CRGO N/A
- EPRX N/A
- Fundamental
- Price
- CRGO $3.92
- EPRX $3.20
- Analyst Decision
- CRGO Strong Buy
- EPRX Strong Buy
- Analyst Count
- CRGO 2
- EPRX 1
- Target Price
- CRGO $4.75
- EPRX $9.00
- AVG Volume (30 Days)
- CRGO 106.8K
- EPRX 6.9K
- Earning Date
- CRGO 02-24-2025
- EPRX 02-07-2025
- Dividend Yield
- CRGO N/A
- EPRX N/A
- EPS Growth
- CRGO N/A
- EPRX N/A
- EPS
- CRGO N/A
- EPRX N/A
- Revenue
- CRGO $22,456,000.00
- EPRX N/A
- Revenue This Year
- CRGO $18.98
- EPRX N/A
- Revenue Next Year
- CRGO $27.78
- EPRX N/A
- P/E Ratio
- CRGO N/A
- EPRX N/A
- Revenue Growth
- CRGO 13.00
- EPRX N/A
- 52 Week Low
- CRGO $1.27
- EPRX $2.20
- 52 Week High
- CRGO $4.08
- EPRX $4.08
- Technical
- Relative Strength Index (RSI)
- CRGO 75.78
- EPRX N/A
- Support Level
- CRGO $2.88
- EPRX N/A
- Resistance Level
- CRGO $3.30
- EPRX N/A
- Average True Range (ATR)
- CRGO 0.32
- EPRX 0.00
- MACD
- CRGO 0.04
- EPRX 0.00
- Stochastic Oscillator
- CRGO 89.15
- EPRX 0.00
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.